SCHEMBL316570

SCHEMBL316570

O=C(NC1CCC(Cc2ccccc2)(N2CCCC2)CC1)c1cccnc1Sc1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
HTT P42858 1/20 0.47
P2RX7 Q99572 1/20 0.46
ATM Q13315 1/20 0.45
HSD11B1 P28845 2/20 0.43
RAB9A P51151 1/20 0.43
CNR2 P34972 2/20 0.42
CNR1 P21554 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SLC6A12 P48065 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL315816 0.93 ALDH1A1 (0.52) ALDH1A1HTTP2RX7ATMHSD11B1
SCHEMBL316867 0.78 CNR2 (0.54) ALDH1A1CNR2CNR1
SCHEMBL316670 0.78 CNR2 (0.56) ALDH1A1CNR2CNR1KMT2AMEN1
SCHEMBL316655 0.77 ALDH1A1 (0.49) ALDH1A1HTTATMHSD11B1RAB9A
SCHEMBL315994 0.77 ALDH1A1 (0.49) ALDH1A1HTTHSD11B1RAB9ACNR2
SCHEMBL316531 0.75 ALDH1A1 (0.52) ALDH1A1HTTATMHSD11B1RAB9A
SCHEMBL314971 0.75 ALDH1A1 (0.56) ALDH1A1HTTATMHSD11B1RAB9A
SCHEMBL316412 0.75 L3MBTL1 (0.51) ALDH1A1HTTATMHSD11B1RAB9A
SCHEMBL316180 0.74 ALDH1A1 (0.51) ALDH1A1HTTATMHSD11B1RAB9A
SCHEMBL2987821 0.74 ATF4 (0.58) ALDH1A1RAB9AKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP claimed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US claimed
JP-2007536321-A 2007-12-13 JP claimed
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-06-07 US claimed
EP-1745009-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2007-01-24 EP claimed
WO-2005110971-A1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2005-11-24 WO claimed
EP-1745009-B1 HETEROARYL SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2012-11-14 EP disclosed
US-8093272-B2 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2012-01-10 US disclosed
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129369-A1 Heteroaryl substituted cyclohexyl-1,4-diamine compounds DDC, DPYD, PKD1 ALDH1A1 119/4885HTT 440/4885P2RX7 2408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.